{"AllianceGenome": "11378", "HGNC": "11378", "MIM": "604415", "_id": "26872", "_version": 1, "accession": {"genomic": ["AC004969.1", "CH236949.1", "CH471073.1", "CP068271.2", "CS283329.1", "NC_000007.14", "NC_060931.1"], "protein": ["AAD15620.2", "AAF17479.1", "AAH11802.1", "BAG64983.1", "CAJ90613.1", "EAL24166.1", "EAL24167.1", "EAW93749.1", "EAW93750.1", "EAW93751.1", "EAW93752.1", "NP_036581.1", "Q9UHE8.1"], "rna": ["AF186249.1", "AK304076.1", "AK308452.1", "BC011802.2", "BI549469.1", "NM_012449.3"], "translation": [{"protein": "AAH11802.1", "rna": "BC011802.2"}, {"protein": "AAF17479.1", "rna": "AF186249.1"}, {"protein": "BAG64983.1", "rna": "AK304076.1"}, {"protein": "NP_036581.1", "rna": "NM_012449.3"}]}, "alias": ["PRSS24", "STEAP"], "ec": "1.16.1.-", "ensembl": {"gene": "ENSG00000164647", "protein": ["ENSP00000297205", "ENSP00000394402"], "transcript": ["ENST00000297205", "ENST00000412573", "ENST00000475789"], "translation": [{"protein": "ENSP00000297205", "rna": "ENST00000297205"}, {"protein": "ENSP00000394402", "rna": "ENST00000412573"}], "type_of_gene": "protein_coding"}, "entrezgene": "26872", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 9.41989517, "exp_mis": 87.6673455, "exp_syn": 36.825116, "lof_z": 2.39477333996039, "mis_z": -0.121856055429426, "mu_lof": 6.83439306331e-07, "mu_mis": 7.58953037662e-06, "mu_syn": 3.10221406071e-06, "n_lof": 2.0, "n_mis": 90.0, "n_syn": 23.0, "p_li": 0.434511093853516, "p_null": 0.00703185280846302, "p_rec": 0.558457053338021, "syn_z": 1.41236282370989}, "bp": 1020, "cds_end": 89794048, "cds_start": 89789102, "n_exons": 4, "nonpsych": {"exp_lof": 8.4433718, "exp_mis": 79.2648673, "exp_syn": 33.2477407, "lof_z": 2.17774586867871, "mis_z": 0.0150056241985098, "mu_lof": 6.83439306331e-07, "mu_mis": 7.58953037662e-06, "mu_syn": 3.10221406071e-06, "n_lof": 2.0, "n_mis": 79.0, "n_syn": 19.0, "p_li": 0.377162310226454, "p_null": 0.0130191814865705, "p_rec": 0.609818508286975, "syn_z": 1.55570919355607}, "nontcga": {"exp_lof": 8.65825823, "exp_mis": 80.645918, "exp_syn": 33.87106186, "lof_z": 2.23216667707927, "mis_z": -0.352509982572309, "mu_lof": 6.83439306331e-07, "mu_mis": 7.58953037662e-06, "mu_syn": 3.10221406071e-06, "n_lof": 2.0, "n_mis": 87.0, "n_syn": 21.0, "p_li": 0.374552513309754, "p_null": 0.0109630195593195, "p_rec": 0.614484467130926, "syn_z": 1.40030371131081}, "transcript": "ENST00000297205.2"}, "exons": [{"cdsend": 90164734, "cdsstart": 90159788, "chr": "7", "position": [[90154468, 90154543], [90159757, 90159872], [90160804, 90161317], [90161913, 90162078], [90164476, 90164827]], "strand": 1, "transcript": "NM_012449", "txend": 90164827, "txstart": 90154468}], "exons_hg19": [{"cdsend": 89794048, "cdsstart": 89789102, "chr": "7", "position": [[89783782, 89783857], [89789071, 89789186], [89790118, 89790631], [89791227, 89791392], [89793790, 89794141]], "strand": 1, "transcript": "NM_012449", "txend": 89794141, "txstart": 89783782}], "generif": [{"pubmed": 15958640, "text": "Peptide STEAP-292.2L (MLAVFLPIV) may have potential as an antitumor peptide vaccine."}, {"pubmed": 18793824, "text": "STEAP mRNA is used here as a marker to evaluate biological samples from individuals suspected of having cancers, and may provide prognostic information useful in defining appropriate therapeutic options."}, {"pubmed": 18958632, "text": "STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol."}, {"pubmed": 19124506, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19196137, "text": "STEAPs may represent novel markers of mesenchymal stem cells in man as well as mice."}, {"pubmed": 19915386, "text": "Data suggest that zoledronic acid may affect cancer cells also by targeting the gene expression of STEAP."}, {"pubmed": 20628624, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21928126, "text": "Studies suggest that activated human gammadelta T cells can efficiently present PRAME and STEAP1-derived epitopes and allow breaking tolerance against these tumor-associated self-antigens."}, {"pubmed": 22080479, "text": "EWS-FLI1 mediated overexpression of STEAP1 increases the invasiveness and oxidative stress levels of Ewing tumor cells."}, {"pubmed": 22080479, "text": "STEAP1 is associated with the invasive behavior and oxidative stress phenotype of Ewing tumors, an unanticipated oncogenic function of STEAP1."}, {"pubmed": 22317770, "text": "A total of 62.3% of the Ewing's Sarcoma samples displayed detectable STEAP1 expression with predominant localization of the protein at the plasma membrane."}, {"pubmed": 22317770, "text": "STEAP1 overexpression predicts improved outcome of Ewing's sarcoma patients, possibly due to enhanced sensitivity towards ROS-generating chemotherapeutics."}, {"pubmed": 23060075, "text": "STEAP1 is down-regulated by dihydrotestosterone and estradiols in LNCaP cells and in rat prostate."}, {"pubmed": 24025158, "text": "The findings provide evidence that STEAP1 is a biomarker of worse prognosis in prostate carcinomas patients."}, {"pubmed": 24239460, "text": "Data indicate that six transmembrane epithelial antigen of the prostate 1 (STEAP1) is consistently overexpressed in malignant prostate tissue, namely adenocarcinoma and prostatic intraepithelial neoplasia (PIN) lesions."}, {"pubmed": 25453051, "text": "These findings highlight the ability of immuno-PET with (89)Zr-2109A to detect acute changes in STEAP1 expression"}, {"pubmed": 27792302, "text": "Data suggest a solid basis for further research into understanding how six-transmembrane epithelial antigen of prostate member 1 (STEAP1) activities may affect cancer progression."}, {"pubmed": 29464393, "text": "High STEAP1 expression is associated with prostate cancer."}, {"pubmed": 30027616, "text": "The expression of STEAP-1 is significantly associated with high-grade Gleason scores and seminal vesicle invasion of PCa."}, {"pubmed": 30253922, "text": "Low STEAP1 expression was associated with Breast Cancer Metastasis."}, {"pubmed": 30401882, "text": "we identified high STEAP1 transcript levels leading to reduced ROS production that prevented apoptosis via the NRF2 pathway in CRC cells as a pathological mechanism in CRC."}, {"pubmed": 32382787, "text": "Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition."}, {"pubmed": 32409586, "text": "Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1)."}, {"pubmed": 32515474, "text": "STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway."}, {"pubmed": 32802887, "text": "The Tumor Suppressive Roles and Prognostic Values of STEAP Family Members in Breast Cancer."}, {"pubmed": 33128353, "text": "A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos."}, {"pubmed": 33589770, "text": "Clinical significance of STEAP1 extracellular vesicles in prostate cancer."}, {"pubmed": 34073779, "text": "Identification of a New Transcriptional Co-Regulator of STEAP1 in Ewing's Sarcoma."}, {"pubmed": 34649092, "text": "Predictive potential of STEAP family for survival, immune microenvironment and therapy response in glioma."}, {"pubmed": 35313641, "text": "The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis."}, {"pubmed": 36660947, "text": "STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide."}, {"pubmed": 37209327, "text": "Inhibition of STEAP1 ameliorates inflammation and ferroptosis of acute lung injury caused by sepsis in LPS-induced human pulmonary microvascular endothelial cells."}, {"pubmed": 37315586, "text": "Proteomic analysis of STEAP1 knockdown in human LNCaP prostate cancer cells."}, {"pubmed": 38062846, "text": "Six Transmembrane Epithelial Antigen 1 as a Prognostic Biomarker in Carcinomas: A Meta-Analysis."}], "genomic_pos": {"chr": "7", "end": 90164829, "ensemblgene": "ENSG00000164647", "start": 90154456, "strand": 1}, "genomic_pos_hg19": {"chr": "7", "end": 89794143, "start": 89783689, "strand": 1}, "go": {"CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005768", "qualifier": "is_active_in", "term": "endosome"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 32409586, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005911", "pubmed": 10588738, "qualifier": "located_in", "term": "cell-cell junction"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0010008", "qualifier": "located_in", "term": "endosome membrane"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 19946888, "qualifier": "located_in", "term": "membrane"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0020037", "pubmed": 32409586, "qualifier": "enables", "term": "heme binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0052851", "pubmed": 32409586, "qualifier": "NOT enables", "term": "ferric-chelate reductase (NADPH) activity"}]}, "homologene": {"genes": [[8364, 100494347], [9031, 420540], [9544, 704448], [9598, 463951], [9606, 26872], [9615, 475222], [9913, 515156], [10090, 70358], [10116, 297738]], "id": 8256}, "interpro": {"desc": "Ferric reductase transmembrane component-like domain", "id": "IPR013130", "short_desc": "Fe3_Rdtase_TM_dom"}, "ipi": "IPI00005846", "map_location": "7q21.13", "name": "STEAP family member 1", "other_names": ["STEAP1 metalloreductase", "STEAP1 protein", "metalloreductase STEAP1", "six transmembrane epithelial antigen of the prostate 1", "six-transmembrane epithelial antigen of prostate 1"], "pantherdb": {"HGNC": "11378", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1917608", "ortholog_type": "LDO", "panther_family": "PTHR14239", "taxid": 10090, "uniprot_kb": "Q9CWR7"}, {"RGD": "1311543", "ortholog_type": "LDO", "panther_family": "PTHR14239", "taxid": 10116, "uniprot_kb": "D3ZEK7"}, {"Ensembl": "ENSGALG00000009006", "ortholog_type": "LDO", "panther_family": "PTHR14239", "taxid": 9031, "uniprot_kb": "E1BTZ9"}], "uniprot_kb": "Q9UHE8"}, "pathway": {"kegg": {"id": "hsa04978", "name": "Mineral absorption - Homo sapiens (human)"}, "wikipathways": {"id": "WP3286", "name": "Copper homeostasis"}}, "pdb": ["6Y9B", "8UCD"], "pfam": "PF01794", "pharmgkb": "PA36193", "pharos": {"target_id": 3313, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF170407", "relationship": "is"}, {"id": "GNF192219", "relationship": "is"}, {"id": "GNF203125", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF036884", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF014098", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF286532", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF107147", "relationship": "is"}, {"id": "GNF146793", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000007.14", "NC_060931.1"], "protein": "NP_036581.1", "rna": "NM_012449.3", "translation": {"protein": "NP_036581.1", "rna": "NM_012449.3"}}, "reporter": {"HG-U133_Plus_2": "205542_at", "HG-U95Av2": "40297_at", "HTA-2_0": "TC07000536.hg.1", "HuEx-1_0": ["3011838", "3041122"], "HuGene-1_1": "8134030", "HuGene-2_1": "17048072"}, "summary": "This gene is predominantly expressed in prostate tissue, and is found to be upregulated in multiple cancer cell lines. The gene product is predicted to be a six-transmembrane protein, and was shown to be a cell surface antigen significantly expressed at cell-cell junctions. [provided by RefSeq, Jul 2008].", "symbol": "STEAP1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1539881"}, "unigene": "Hs.61635", "uniprot": {"Swiss-Prot": "Q9UHE8", "TrEMBL": "H7C0D8"}, "wikipedia": {"url_stub": "STEAP1"}}